RTTNews | Feb 11, 2021 05:20PM EST

17:20 Thursday, February 11, 2021 (RTTNews.com) - Ultragenyx Pharmaceutical Inc. (RARE) Thursday reported fourth-quarter loss of $24.0 million or $0.37 per share, wider than last year' loss of $93.8 million or $1.62 per share.

Revenues for the quarter grew to $91.5 million from $35.6 million last year.

Analysts polled by Thomson Reuters estimated a loss of $1.16 per share on revenues of $70.54 million.

Read the original article on RTTNews ( https://www.rttnews.com/3169217/ultragenyx-pharmaceutical-q4-loss-widens.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved